|
05/22/13
|
Executive Session
|
S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act, NLRB Nominations
|
|
05/14/13
|
Full Committee Hearing
|
The ADA and Entertainment Technologies: Improving Accessibility from the Movie Screen to Your Mobile Device
|
|
05/09/13
|
Full Committee Hearing
|
Pharmaceutical Compounding: Proposed Legislative Solution
|
|
04/23/13
|
Subcommittee Hearing
|
Successful Primary Care Programs: Creating the Workforce We Need
|
|
04/11/13
|
Full Committee Hearing
|
A New, Open Marketplace: The Effect of Guaranteed Issue and New Rating Rules
|
|
04/10/13
|
Executive Session
|
S. 689, Mental Health Awareness and Improvement Act of 2013, and Nominations
|
|
02/27/13
|
Full Committee Hearing
|
Animal Drug User Fee Agreements: Advancing Animal Health for the Public Health
|
|
01/24/13
|
Full Committee Hearing
|
Assessing the State of America’s Mental Health System
|
|
11/15/12
|
Full Committee Hearing
|
Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak
|
|
08/30/12
|
Full Committee Field Hearing
|
Lyme Disease: A Comprehensive Approach to an Evolving Threat
|
|
07/13/12
|
Full Committee Field Hearing
|
The Americans with Disabilities Act at 22: A New Generation of Iowans Approaches the Labor Force with High Expectations
|
|
06/13/12
|
Executive Session
|
Nominations
|
|
05/30/12
|
Full Committee Field Hearing
|
Ensuring Patients’ Access to Care and Privacy: Are Federal Laws Protecting Patients?
|
|
05/16/12
|
Full Committee Hearing
|
Identifying Opportunities for Health Care Delivery System Reform: Lessons from the Front Line
|
|
05/15/12
|
Subcommittee Hearing
|
The High Cost of High Prices for HIV/AIDS Drugs and the Prize Fund Alternative
|